XML 100 R87.htm IDEA: XBRL DOCUMENT
v3.22.0.1

Summary of Warrant Activity (Details) - $ / shares | 12 Months Ended |
--- | --- | ---
Dec. 31, 2020 | Dec. 31, 2019 | Sep. 30, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items] |  |  |
Outstanding, Classified as Derivative Liabilities | 2,375,000 |  | 2,375,000
Outstanding, Classified within Stockholders' Equity | 507,055 |  | 507,055
Total Exercisable | 2,882,055 |  | 2,882,055
Number of Shares, Exercisable at end of year | 2,882,055 |  |
Publisher Partner Warrant [Member] |  |  |
Accumulated Other Comprehensive Income (Loss) [Line Items] |  |  |
Total Exercisable | 463,041 |  |
Number of Shares, outstanding, at beginning of year | 939,541 | 1,017,140 |
Number of Shares, outstanding at end of year | 789,541 | 939,541 |
Number of Shares, Exercisable at end of year | 463,041 |  |
Weighted Average Exercise Price, Exercisable at end of year | $ 1.31 |  |
Weighted Average Exercise Price, outstanding, at beginning of year | $ 1.46 | $ 1.47 |
Weighted Average Remaining Contractual Life, Outstanding at beginning of year |  | 3 years 3 months 3 days |
Number of Shares, Forfeited | (150,000) | (77,599) |
Weighted Average Exercise Price, Forfeited |  | $ 1.62 |
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding-2] | $ 1.34 | $ 1.46 |
Weighted Average Remaining Contractual Life, Outstanding at ending of year | 1 year 6 months | 2 years 6 months 25 days |
Weighted Average Remaining Contractual Life, Exercisable | 1 year 6 months 7 days |  |
Number of Shares, not vested at end of year | 326,500 |  |
Number of Shares, Available for future grants at end of year | 1,210,459 |  |
Common Stock Financing Warrant [Member] |  |  |
Accumulated Other Comprehensive Income (Loss) [Line Items] |  |  |
Total Exercisable | 2,882,055 |  |
Number of Shares, outstanding, at beginning of year | 2,882,055 | 3,949,018 |
Weighted Average Exercise Price, outstanding, at beginning of year | $ 0.80 | $ 0.64 |
Weighted Average Remaining Contractual Life, Outstanding at beginning of year |  | 4 years 9 months 21 days |
Number of Shares, Exercised |  | (1,066,963) |
Weighted Average Exercise Price, Exercised |  |  |
Number of Shares, outstanding at end of year | 2,882,055 | 2,882,055 |
Weighted Average Exercise Price, outstanding, at end of year | $ 0.60 | $ 0.80 |
Weighted Average Remaining Contractual Life, Outstanding at end of year | 2 years 11 months 8 days | 3 years 11 months 12 days |
Number of Shares, Exercisable at end of year | 2,882,055 |  |
Weighted Average Exercise Price, Exercisable at end of year | $ 0.60 |  |
Weighted Average Remaining Contractual Life, Exercisable at end of year | 2 years 11 months 8 days |  |
MDB Warrants [Member] |  |  |
Accumulated Other Comprehensive Income (Loss) [Line Items] |  |  |
Exercise Price |  |  | $ 0.20
Expiration Date |  |  | Nov. 04, 2021
Outstanding, Classified as Derivative Liabilities |  |  |
Outstanding, Classified within Stockholders' Equity | 327,490 |  | 327,490
Total Exercisable | 327,490 |  | 327,490
Number of Shares, Exercisable at end of year | 327,490 |  |
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding-2] | $ 0.20 |  |
Strome Warrants [Member] |  |  |
Accumulated Other Comprehensive Income (Loss) [Line Items] |  |  |
Exercise Price |  |  | $ 0.50
Expiration Date |  |  | Jun. 15, 2023
Outstanding, Classified as Derivative Liabilities | 1,500,000 |  | 1,500,000
Outstanding, Classified within Stockholders' Equity |  |  |
Total Exercisable | 1,500,000 |  | 1,500,000
Number of Shares, Exercisable at end of year | 1,500,000 |  |
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding-2] | $ 0.50 |  |
B. Riley Warrants [Member] |  |  |
Accumulated Other Comprehensive Income (Loss) [Line Items] |  |  |
Exercise Price |  |  | $ 0.33
Expiration Date |  |  | Oct. 18, 2025
Outstanding, Classified as Derivative Liabilities | 875,000 |  | 875,000
Outstanding, Classified within Stockholders' Equity |  |  |
Total Exercisable | 875,000 |  | 875,000
Number of Shares, Exercisable at end of year | 875,000 |  |
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding-2] | $ 1.00 |  |
MDB Warrants One [Member] |  |  |
Accumulated Other Comprehensive Income (Loss) [Line Items] |  |  |
Exercise Price |  |  | $ 1.15
Expiration Date |  |  | Oct. 19, 2022
Outstanding, Classified as Derivative Liabilities |  |  |
Outstanding, Classified within Stockholders' Equity | 119,565 |  | 119,565
Total Exercisable | 119,565 |  | 119,565
Number of Shares, Exercisable at end of year | 119,565 |  |
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding-2] | $ 1.15 |  |
MDB Warrants Two [Member] |  |  |
Accumulated Other Comprehensive Income (Loss) [Line Items] |  |  |
Exercise Price |  |  | $ 2.50
Expiration Date |  |  | Oct. 19, 2022
Outstanding, Classified as Derivative Liabilities |  |  |
Outstanding, Classified within Stockholders' Equity | 60,000 |  | 60,000
Total Exercisable | 60,000 |  | 60,000
Number of Shares, Exercisable at end of year | 60,000 |  |
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding-2] | $ 2.50 |  |

X
- Definition Financing warrants classified as derivative liabilities (shares). + References No definition available. + Details
Name: | MVEN_FinancingWarrantsClassifiedAsDerivativeLiabilitiesShares
Namespace Prefix: | MVEN_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Financing warrants classified within stockholders' equity (shares). + References No definition available. + Details
Name: | MVEN_FinancingWarrantsClassifiedWithinStockholdersEquityShares
Namespace Prefix: | MVEN_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Financing warrant, exercisable. + References No definition available. + Details
Name: | MVEN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable
Namespace Prefix: | MVEN_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of shares, not vested. + References No definition available. + Details
Name: | MVEN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentNonVested
Namespace Prefix: | MVEN_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of shares, available for future grants. + References No definition available. + Details
Name: | MVEN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAvailableForFutureGrantsNumber
Namespace Prefix: | MVEN_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Weighted Average Exercise Price, Exercised. + References No definition available. + Details
Name: | MVEN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised
Namespace Prefix: | MVEN_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Weighted Average Exercise Price, Forfeited. + References No definition available. + Details
Name: | MVEN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceForfeited
Namespace Prefix: | MVEN_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Weighted average exercise price outstanding. + References No definition available. + Details
Name: | MVEN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding
Namespace Prefix: | MVEN_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Weighted Average Exercise Price, Exercisable at end of year. + References No definition available. + Details
Name: | MVEN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstandingExercisable
Namespace Prefix: | MVEN_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of warrants outstanding, including both vested and non-vested options. + References No definition available. + Details
Name: | MVEN_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingNumber
Namespace Prefix: | MVEN_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Weighted average remaining contractual term for vested portions of warrants outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | MVEN_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisableWeightedAverageRemainingContractualTerm1
Namespace Prefix: | MVEN_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Weighted average remaining contractual term for warrants awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | MVEN_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTerm1
Namespace Prefix: | MVEN_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Weighted average remaining contractual term for warrants awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | MVEN_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTerm2
Namespace Prefix: | MVEN_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Weighted average remaining contractual life exercisable. + References No definition available. + Details
Name: | MVEN_WeightedAverageRemainingContractualLifeExercisable
Namespace Prefix: | MVEN_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Weighted average remaining contractual life, outstanding. + References No definition available. + Details
Name: | MVEN_WeightedAverageRemainingContractualLifeOutstanding
Namespace Prefix: | MVEN_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Weighted Average Remaining Contractual Life, Outstanding. + References No definition available. + Details
Name: | MVEN_WeightedAverageRemainingContractualLifeOutstanding1
Namespace Prefix: | MVEN_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Exercise price per share or per unit of warrants or rights outstanding. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644 + Details
Name: | us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of non-option equity instruments exercised by participants. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(2) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(3) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(ii) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(i) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (bbb)(2) -URI http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258 + Details
Name: | us-gaap_WarrantsAndRightsOutstandingMaturityDate
Namespace Prefix: | us-gaap_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | us-gaap_PlanNameAxis=MVEN_PublisherPartnerWarrantProgramMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=MVEN_CommonStockFinancingWarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=MVEN_MDBWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=MVEN_StromeWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=MVEN_BRileyWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=MVEN_MDBWarrantsOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=MVEN_MDBWarrantsTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |